Cost‐effectiveness analysis of hepatitis C virus (HCV) point‐of‐care assay for HCV screening

V Koo, F Tian, WWL Wong - Liver International, 2022 - Wiley Online Library
Abstract Background & Aims Hepatitis C virus (HCV) continues to pose significant public
health concerns with approximately 44% of chronically infected Canadians undiagnosed …
被引用次数：7 相关文章

Cost‐effectiveness analysis of hepatitis C virus (HCV) point‐of‐care assay for HCV screening.

V Koo, F Tian, WWL Wong - Liver International, 2022 - search.ebscohost.com
Abstract Background & Aims: Hepatitis C virus (HCV) continues to pose significant
public health concerns with approximately 44% of chronically infected Canadians …

Cost-effectiveness analysis of hepatitis C virus (HCV) point-of-care assay for HCV screening.

V Koo, F Tian, WWL Wong - … of the International Association for the …, 2021 - europepmc.org
Methods A state-transition model based on published literature was developed to compare
HCV point-of-care assay with the standard-of-care blood screening for a one-time HCV …

Cost-effectiveness analysis of hepatitis C virus (HCV) point-of-care assay for HCV screening

V Koo, F Tian, WWL Wong - … for the Study of the Liver, 2022 - pubmed.ncbi.nlm.nih.gov
Background & aims Hepatitis C virus (HCV) continues to pose significant public health
concerns with approximately 44% of chronically infected Canadians undiagnosed. The …